Lee Kalowski

Lee Kalowski

Net worth: 62 150 $ as of 2024-03-30

43 year
Health Technology
Finance
Consumer Services

Profile

Lee H.
Kalowski
is currently the President & Chief Financial Officer at Q32 Bio, Inc. He previously held positions as VP-Global Biotechnology Equity Research at Credit Suisse Securities (USA) LLC, Research Analyst at Sanford C.
Bernstein & Co. LLC, Research Analyst at Prudential Equity Group LLC, Chief Financial Officer at Tokai Pharmaceuticals, Inc., and President & Chief Financial Officer at Bicycle Therapeutics Plc.
He also served as Chief Financial Officer at Eledon Pharmaceuticals, Inc. and President & Chief Financial Officer at Bicycle Therapeutics, Inc. Mr. Kalowski completed his undergraduate degree at Union College (New York) in 2003 and obtained an MBA from The Wharton School of the University of Pennsylvania in 2010.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
2023-04-19 2,496 ( 0.01% ) 62 150 $ 2024-03-30
-.--%
2024-03-24 0 ( -.--% ) - $ 2024-03-30

Lee Kalowski active positions

Former positions of Lee Kalowski

CompaniesPositionEnd
Director of Finance/CFO 2023-06-21
BICYCLE THERAPEUTICS PLC President 2023-06-21
Director of Finance/CFO 2016-08-30
ELEDON PHARMACEUTICALS, INC. Director of Finance/CFO 2016-07-31
Analyst-Equity -
See the detail of Lee Kalowski's experience

Training of Lee Kalowski

Union College (New York) Undergraduate Degree
The Wharton School of the University of Pennsylvania Masters Business Admin

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Lee Kalowski's experience

Connections

99

1st degree connections

9

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies2
BICYCLE THERAPEUTICS PLC

Health Technology

ELEDON PHARMACEUTICALS, INC.

Health Technology

Private companies5

Finance

Finance

Finance

Health Technology

Health Technology

See company connections